Phase II Clinical Trial for Prevention of Delayed Diarrhea with Cholestyramine/Levofloxacin in the Second-Line Treatment with Irinotecan Biweekly in Patients with Metastatic Colorectal Carcinoma
2007
Background:
Irinotecanis an established therapeutic option in colorectal cancer. An essential side effect of
irinotecantreatment is the induction of severe WHO grade 3–4 delayed d
Keywords:
-
Correction
-
Source
-
Cite
-
Save
36
References
28
Citations
NaN
KQI